/ Not yet recruitingNot Applicable [Translation] Study on the bioequivalence of voriconazole dry suspension in healthy volunteers
主要目的:在中国健康参与者中空腹状态下评价河北嵘霖制药有限公司持证的伏立康唑干混悬剂(规格:45 g:3 g)与持证商Pfizer Limited 的伏立康唑干混悬剂(Vfend®,规格:45 g:3 g)的人体生物等效性 。
次要目的:观察受试制剂和参比制剂在健康参与者中的安全性。
[Translation] Primary objective: To evaluate the bioequivalence of voriconazole dry suspension (specification: 45 g:3 g) licensed by Hebei Ronglin Pharmaceutical Co., Ltd. and voriconazole dry suspension (Vfend®, specification: 45 g:3 g) licensed by Pfizer Limited in healthy Chinese participants under fasting condition.
Secondary objective: To observe the safety of the test and reference preparations in healthy participants.
100 Clinical Results associated with Hebei Ronglin Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Hebei Ronglin Pharmaceutical Co., Ltd.
100 Deals associated with Hebei Ronglin Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Hebei Ronglin Pharmaceutical Co., Ltd.